Log In
Print this Print this

Dermagraft (ABH001)

  Manage Alerts
Collapse Summary General Information
Company Organogenesis Inc.
DescriptionEngineered skin substitute containing live human fibroblasts grown on an absorbable Vicryl mesh
Molecular Target Not available
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentMarketed
Standard IndicationDermal ulcers
Indication DetailsPressure ulcers and skin ulcers (diabetic and venous); Treat chronic foot ulcers; Treat diabetic foot ulcers; Treat venous leg ulcers
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today